"GDF-15 is a prominent molecule used by tumours to keep the immune system at bay, mirroring its physiological role in feto-maternal tolerance towards placental alloantigens."
"The GDFATHER clinical trial of the GDF-15-blocking antibody visugromab showed promising results, combining it with anti-PD-1 to enhance the treatment of relapsed or refractory cancer patients."
Collection
[
|
...
]